442 related articles for article (PubMed ID: 27463117)
41. Bosentan for severe pulmonary arterial hypertension related to systemic sclerosis with interstitial lung disease.
Ahmadi-Simab K; Hellmich B; Gross WL
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():44-8. PubMed ID: 16919010
[TBL] [Abstract][Full Text] [Related]
42. Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.
Vandecasteele E; De Pauw M; De Keyser F; Decuman S; Deschepper E; Piette Y; Brusselle G; Smith V
Int J Cardiol; 2016 Jun; 212():265-73. PubMed ID: 27057932
[TBL] [Abstract][Full Text] [Related]
43. Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosis.
Steen V; Chou M; Shanmugam V; Mathias M; Kuru T; Morrissey R
Chest; 2008 Jul; 134(1):146-51. PubMed ID: 18403670
[TBL] [Abstract][Full Text] [Related]
44. Self-reported physical capacity and activity in patients with systemic sclerosis and matched controls.
Pettersson H; Åkerström A; Nordin A; Svenungsson E; Alexanderson H; Boström C
Scand J Rheumatol; 2017 Nov; 46(6):490-495. PubMed ID: 28303747
[TBL] [Abstract][Full Text] [Related]
45. Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement.
Abdel-Magied RA; Kamel SR; Said AF; Ali HM; Abdel Gawad EA; Moussa MM
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):321-330. PubMed ID: 28079844
[TBL] [Abstract][Full Text] [Related]
46. Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement.
de Oliveira NC; dos Santos Sabbag LM; Ueno LM; de Souza RB; Borges CL; de Sá Pinto AL; Lima FR
Scand J Rheumatol; 2007; 36(6):458-61. PubMed ID: 18092268
[TBL] [Abstract][Full Text] [Related]
47. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
[TBL] [Abstract][Full Text] [Related]
48. Six-minute walk distance as parameter of functional outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Reesink HJ; van der Plas MN; Verhey NE; van Steenwijk RP; Kloek JJ; Bresser P
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):510-6. PubMed ID: 17258590
[TBL] [Abstract][Full Text] [Related]
49. Relation of exercise capacity with lung volumes before and after 6-minute walk test in subjects with COPD.
Wibmer T; Rüdiger S; Kropf-Sanchen C; Stoiber KM; Rottbauer W; Schumann C
Respir Care; 2014 Nov; 59(11):1687-95. PubMed ID: 25249649
[TBL] [Abstract][Full Text] [Related]
50. Assessment of left and right ventricular diastolic function in patients with systemic sclerosis.
Ciurzyński M; Bienias P; Lichodziejewska B; Szewczyk A; Glińska-Wielochowska M; Jankowski K; Kurnicka K; Kurzyna M; Gliński W; Pruszczyk P
Kardiol Pol; 2008 Mar; 66(3):269-76, discussion 277-8. PubMed ID: 18393114
[TBL] [Abstract][Full Text] [Related]
51. Impaired chronotropic response to 6-min walk test and reduced survival in interstitial lung disease.
Holland AE; Hill CJ; Glaspole I; Goh N; Dowman L; McDonald CF
Respir Med; 2013 Jul; 107(7):1066-72. PubMed ID: 23669412
[TBL] [Abstract][Full Text] [Related]
52. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity.
Rietema H; Holverda S; Bogaard HJ; Marcus JT; Smit HJ; Westerhof N; Postmus PE; Boonstra A; Vonk-Noordegraaf A
Eur Respir J; 2008 Apr; 31(4):759-64. PubMed ID: 18094009
[TBL] [Abstract][Full Text] [Related]
53. Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters.
Fischer A; Swigris JJ; Bolster MB; Chung L; Csuka ME; Domsic R; Frech T; Hinchcliff M; Hsu V; Hummers LK; Gomberg-Maitland M; Mathai SC; Simms R; Steen VD
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-109-14. PubMed ID: 25372796
[TBL] [Abstract][Full Text] [Related]
54. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients.
Villalba WO; Sampaio-Barros PD; Pereira MC; Cerqueira EM; Leme CA; Marques-Neto JF; Paschoal IA
Chest; 2007 Jan; 131(1):217-22. PubMed ID: 17218579
[TBL] [Abstract][Full Text] [Related]
55. Latent pulmonary inflammation in patients with systemic sclerosis.
Sánchez-Vidaurre S; Simeón CP; Cruz MJ; Fonollosa V; Vilardell M; Morell F; Muñoz X
Arch Bronconeumol; 2012 Jan; 48(1):8-13. PubMed ID: 22133713
[TBL] [Abstract][Full Text] [Related]
56. The effect of global longitudinal strain on ımpaired six-minute walk test performance in patients with sarcoidosis.
Kaptan Ozen D; Mutlu B; Kocakaya D; Turan B; Sert Sekerci S; Ceyhan B; Kepez A; Erdogan O
Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(1):66-73. PubMed ID: 33093770
[TBL] [Abstract][Full Text] [Related]
57. Assessment of pulmonary artery systolic pressures by stress Doppler echocardiography after bilateral lung transplantation.
Kasimir MT; Mereles D; Aigner C; Jaksch P; Benz A; Kreuscher S; Klepetko W; Grünig E
J Heart Lung Transplant; 2008 Jan; 27(1):66-71. PubMed ID: 18187089
[TBL] [Abstract][Full Text] [Related]
58. Six-minute walk test reflects neurohormonal activation and right ventricular function in systemic sclerosis patients.
Irzyk K; Bienias P; Kostrubiec M; Rymarczyk Z; Bartoszewicz Z; Siwicka M; Stelmaszczyk-Emmel A; Górska E; Demkow U; Pruszczyk P; Ciurzyński M
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):18-23. PubMed ID: 23406664
[TBL] [Abstract][Full Text] [Related]
59. Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function.
Maimon N; Salz L; Shershevsky Y; Matveychuk A; Guber A; Shitrit D
Int J Tuberc Lung Dis; 2013 Mar; 17(3):406-11. PubMed ID: 23407231
[TBL] [Abstract][Full Text] [Related]
60. Six-minute walk test in or out in evaluation of systemic sclerosis patients?
Vandecasteele E; Thevissen K; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Brusselle G; Smith V
Clin Exp Rheumatol; 2017; 35 Suppl 106(4):122-129. PubMed ID: 28229829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
